Crohn’s Disease Treatment Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-10　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 12.87 Bn
2033 年預估規模: USD 17.16 Bn
年複合成長率 CAGR: 4.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-02-10頁數 168報告編號 CMI1237

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Crohn’s Disease Treatment Market, North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), Africa (South Africa, North Africa, and Central Africa), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

Crohn’s disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn’s disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in both males and females. There exists no specific cure for the disease, however various therapies can be employed on patients that can help to reduce signs and symptoms of the disease as well as can bring long-term remission. Improvement in long-term prognosis can be achieved through several medications prescribed for the treatment of Crohn’s disease that include anti-inflammatory drugs, immune system suppressers, antibiotics and other medication that helps to control inflammation. Market Dynamics The North America and Europe regions have high incidence of inflammatory bowel disease (IBD) such as Crohn’s disease, which is expected to drive growth of market. For instance, according to an article published in the journal Digestive Medicine Research in December 2020, in North America, the prevalence of IBD is projected to affect approximately 4 million persons by 2030. According to the same source, data from Canada reported a prevalence of IBD at 725 per 100,000 in 2018, which is estimated to rise to 981 by 2030. Thus the increasing prevalence of IBD is expected to drive market growth over the forecast period. Key features of the study • This report provides in-depth analysis of the global crohn’s disease treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global crohn’s disease treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include AbbVie Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi, Takeda Pharmaceutical Company Limited, Mylan N.V., Amgen Inc., and AstraZeneca • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global crohn’s disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crohn’s disease treatment market Market Segmentation • By Drug Type o Antibiotics o Amino Salicylates o Corticosteroids o Immunomodulators o Others • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o E-Commerce • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players o AbbVie Inc. o Janssen Biotech, Inc. o Bristol-Myers Squibb Company o Boehringer Ingelheim GmbH o Pfizer Inc. o Eli Lilly and Company o Novartis AG o Sanofi o Takeda Pharmaceutical Company Limited o Mylan N.V. o Amgen Inc. o AstraZeneca

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Drug Type  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Key Highlights o Market Trends o PORTER’s Five Forces Analysis o Epidemiology o New Product Launch o Product Type Innovation 4. Global Crohn’s Disease Treatment Market, By Drug Type, 2026 – 2033, (US$ Billion) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Antibiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o Amino Salicylates  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o Corticosteroids  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o Immunomodulators  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) 5. Global Crohn’s Disease Treatment Market, By Distribution Channel, 2026 – 2033, (US$ Billion) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Hospital Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) o E-Commerce  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Billion) 6. Global Crohn’s Disease Treatment Market, By Region, 2026 – 2033, (US$ Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2026–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Billion) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Billion) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Billion) o UK o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Billion) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Billion) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Billion) o North Africa o Central Africa o South Africa 7. Competitive Landscape o AbbVie Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Janssen Biotech, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Bristol-Myers Squibb Company  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Boehringer Ingelheim GmbH  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Pfizer Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Eli Lilly and Company  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sanofi  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Takeda Pharmaceutical Company Limited  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mylan N.V.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Amgen Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AstraZeneca  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 8. Section o Research Methodology o About Us

提及公司

AbbVie Inc.Janssen Biotech, Inc.Bristol-Myers Squibb CompanyBoehringer Ingelheim GmbHPfizer Inc.Eli Lilly and CompanyNovartis AGSanofiTakeda Pharmaceutical Company LimitedMylan N.V.Amgen Inc.AstraZeneca

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們